EUVIMEDEUVIMED entdecken
Randomisierte kontrollierte StudieOpen Access · CC BY-NC 4.0

Effects of levcromakalim in patients with migraine aura without headache: An experimental study

Andreas Vinther Thomsen iD, Mohammad Al-Mahdi Al-Karagholi iD, Anders Hougaard iD, Sisse Rye Ostrowski iD, Messoud Ashina

Cephalalgia · 2024

DOI: 10.1177/03331024241274366 ↗

Kurz gefasst

Randomisierte kontrollierte Studie in der Zeitschrift Cephalalgia, 2024. Verfasst von Andreas Vinther Thomsen und 4 weiteren Autor:innen. Beteiligte Einrichtung: Danish Headache Center, Department of Neurology, Rigshospitalet - Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostru…. Hauptthemen laut MEDLINE: Cross-Over Studies, Migraine with Aura, Cromakalim. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 13 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC 4.0). Gefördert von: Lundbeck Foundation.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background/Hypothesis Levcromakalim has previously been shown to induce attacks of migraine with aura in certain individuals. In this study, we tested the migraine-inducing effect of levcromakalim in a cohort of participants with migraine aura without headache.

Methods

In a double-blind, randomized, placebo-controlled cross-over study, eight adult participants with migraine with aura received intravenous infusions of levcromakalim and saline. Headache, aura and associated symptoms were evaluated for 24 h following administration of the study drug. The primary endpoint was occurrence of migraine-like attacks with or without aura in the 24-h observation period.

Results

Five participants (62.5%) developed migraine of any type following levcromakalim compared with three participants (37.5%) following placebo. No participants developed aura following levcromakalim. Conclusion/Interpretation Our findings suggest that the aura-inducing effect of levcromakalim is likely not based on direct induction of cortical spreading depression but may involve activation of the trigeminovascular system. This hypothesis should be further explored in future studies. ClinicalTrials.gov identifier NCT04905654

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cross-Over StudiesMigraine with AuraCromakalimHumansAdultFemaleMaleDouble-Blind MethodMiddle AgedYoung Adult

Stichwörter der Autor:innen

experimental studyheadachemigraine‌

Substanzen

Cromakalim

Autor:innen und Institutionen

  • Danish Headache Center, Department of Neurology, Rigshospitalet - Glostrup, Faculty of Health and Medical Sciences, University of Copenhagen, Glostrup, Denmark.
  • Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  • Department of Neurology, Copenhagen University Hospital - Herlev and Gentofte, Herlev, Denmark.
  • Department of Clinical Immunology, Rigshospitalet, University of Copenhagen, Copenhagen, Denmark.
  • Danish Knowledge Center on Headache Disorders, Glostrup, Denmark.

ORCID-Profile: Andreas Vinther Thomsen, Mohammad Al-Mahdi Al-Karagholi, Anders Hougaard, Sisse Rye Ostrowski

Förderung

  • Lundbeck Foundation

Zitieren

APA

Thomsen, A. V., Al-Karagholi, M. A., Hougaard, A., Ostrowski, S. R., & Ashina, M. (2024). Effects of levcromakalim in patients with migraine aura without headache: An experimental study. Cephalalgia. https://doi.org/10.1177/03331024241274366

Vancouver

Thomsen AV, Al-Karagholi MA, Hougaard A, Ostrowski SR, Ashina M. Effects of levcromakalim in patients with migraine aura without headache: An experimental study. Cephalalgia. 2024. doi:10.1177/03331024241274366

BibTeX
@article{Thomsen2024,
  author = {Thomsen, Andreas Vinther and Al-Karagholi, Mohammad Al-Mahdi and Hougaard, Anders and Ostrowski, Sisse Rye and Ashina, Messoud},
  title = {Effects of levcromakalim in patients with migraine aura without headache: An experimental study},
  journal = {Cephalalgia},
  year = {2024},
  doi = {10.1177/03331024241274366}
}
Kostenlos starten →